Connect with us

Life Sciences

AgiLab Joins the Tetra Partner Network to Accelerate Efficiency and Maximize Quality Control Processes for Biopharma Customers

TetraScience, the Scientific Data Cloud company, announced that AgiLab, provider of a unified laboratory digital platform, has joined the Tetra Partner…

Published

on

This article was originally published by AITHORITY
AgiLab Joins the Tetra Partner Network to Accelerate Efficiency and Maximize Quality Control Processes for Biopharma Customers

TetraScience, the Scientific Data Cloud company, announced that AgiLab, provider of a unified laboratory digital platform, has joined the Tetra Partner Network to help biopharmaceutical customers accelerate R&D efficiency and maximize quality control processes with the Tetra Scientific Data Cloud.

“We’re delighted to partner with AgiLab, who share our commitment to maximize scientific data without restriction,” said Simon Meffan-Main, Ph.D., VP, Tetra Partner Network. “Our partnership will help customers achieve greater productivity and outcomes across the entire value chain including crucial areas such as quality control by using the GXP functionality of our cloud platform.”

Recommended AI News: Blotout Announces New Partnership with Fastly to Improve Meta Ad Spend with Blotout’s EdgeTag

AgiLab provides one system that supports the functionality of an Electronic Lab Notebook (ELN), Laboratory Execution System (LES), Laboratory Information Management Systems (LIMS), and Electronic Batch Record (EBR), which are typically separate system offerings that can create data silos. By merging functionality onto one platform, Agilab customers save time and money while following all day-to-day laboratory processes from sample creation to method execution on a modern cloud based solution.

The Tetra Data Platform (TDP) ingests raw/primary data from thousands of sources and engineers them to a vendor-agnostic format that is harmonized, compliant, liquid, and actionable (known as Tetra Data). By centralizing scientific data into a universally adoptable format, customers can easily set up new workflows and move data quickly, resulting in improved outcomes and productivity.

Recommended AI News: Raising the Ceiling of Code-Free Programming for Robotics and Industrial Automation

“Both AgiLab and TetraScience share a common goal to eliminate data silos so that scientists can easily conduct their research, knowing that they’ll also gain increased outcomes and insights,” said Renaud Acker, CEO, AgiLab. “We are thrilled to join the Tetra Partner Network so that together we can provide even more powerful and effective solutions to customers.”

“Every partner added to the Tetra Partner Network creates value for customers,” said Patrick Grady, TetraScience Chairman and CEO. “As partners and customers continue to accelerate adoption of our open platform, the entire life sciences industry works in lockstep, eliminating data silos and delivering unrestricted scientific data innovation.”

Recommended AI News: Nephio Sees Rapid Growth as More Organizations Commit to Simplify Cloud Native Automation of Telecom Network Functions

[To share your insights with us, please write to sghosh@martechseries.com]

The post AgiLab Joins the Tetra Partner Network to Accelerate Efficiency and Maximize Quality Control Processes for Biopharma Customers appeared first on AiThority.


life sciences

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Markets

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending